Crohn's disease

G Roda, S Chien Ng, PG Kotze, M Argollo… - Nature Reviews …, 2020 - nature.com
Crohn's disease is an inflammatory bowel disease that is characterized by chronic
inflammation of any part of the gastrointestinal tract, has a progressive and destructive …

The burden of inflammatory bowel disease in Europe in 2020

M Zhao, L Gönczi, PL Lakatos… - Journal of Crohn's and …, 2021 - academic.oup.com
New data suggest that incidence and prevalence of inflammatory bowel diseases [IBD] are
still increasing worldwide, and approximately 0.2% of the European population suffer from …

Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations …

F Magro, P Gionchetti, R Eliakim… - Journal of Crohn's …, 2017 - academic.oup.com
1.2. Definitions Ulcerative colitis [UC] is a chronic inflammatory condition that causes
continuous mucosal inflammation of the colon, usually without granulomas on biopsy. It …

Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target

L Peyrin-Biroulet, W Sandborn, BE Sands… - Official journal of the …, 2015 - journals.lww.com
OBJECTIVES: The Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE)
program was initiated by the International Organization for the Study of Inflammatory Bowel …

Natural history of adult ulcerative colitis in population-based cohorts: a systematic review

M Fumery, S Singh, PS Dulai… - Clinical …, 2018 - Elsevier
Background & Aims A comprehensive knowledge of the natural history of ulcerative colitis
(UC) helps understand disease evolution, identify poor prognostic markers and impact of …

[HTML][HTML] Gold nanoparticles-embedded ceria with enhanced antioxidant activities for treating inflammatory bowel disease

M Li, J Liu, L Shi, C Zhou, M Zou, D Fu, Y Yuan, C Yao… - Bioactive Materials, 2023 - Elsevier
The excessive reactive oxygen species (ROS) is a hallmark associated with the initiation
and progression of inflammatory bowel disease (IBD), which execrably form a vicious cycle …

The burden of inflammatory bowel disease in Europe

J Burisch, T Jess, M Martinato… - Journal of Crohn's …, 2013 - academic.oup.com
Inflammatory bowel diseases (IBD) are chronic disabling gastrointestinal disorders
impacting every aspect of the affected individual's life and account for substantial costs to the …

Ulcerative colitis and Crohn's disease have similar burden and goals for treatment

C Le Berre, AN Ananthakrishnan, S Danese… - Clinical …, 2020 - Elsevier
It is unclear whether ulcerative colitis (UC) is a progressive disease similar to Crohn's
disease (CD). Patients with UC often are undertreated because of the possibility of curative …

Tumor necrosis factor inhibitors for inflammatory bowel disease

OH Nielsen, MA Ainsworth - New England Journal of Medicine, 2013 - Mass Medical Soc
Tumor Necrosis Factor Inhibitors for Inflammatory Bowel Disease | New England Journal of
Medicine Skip to main content The New England Journal of Medicine homepage Advanced …

The IL23-IL17 immune axis in the treatment of ulcerative colitis: successes, defeats, and ongoing challenges

D Noviello, R Mager, G Roda, RG Borroni… - Frontiers in …, 2021 - frontiersin.org
Ulcerative colitis (UC) is a chronic relapsing disorder of the colonic tract, characterized by a
dysregulated innate and adaptive immune response to gut microbiota that contributes to the …